Company profile KA

Kineta Inc
proteostasis therapeutics is discovering and developing novel small molecule therapeutics designed to control the body’s protein homeostasis, or proteostasis network. the proteostasis network maintains the body’s natural balance of proteins to protect us from numerous diseases. these novel therapies, or proteostasis regulators, are designed to treat multiple genetic and deg...enerative disorders associated with deficiencies of the proteostasis network, such as alzheimer’s disease, emphysema, huntington’s disease, and type ii diabetes. Show More
Quarter analysis & expected interestLast update: February 09 2024 04:45:14.

After 39 days of this quarter the interest is at 53.0. Based on that we can calculate that during remaining 52 days it will total up to 124.0.
Kineta expected interest is significantly lower compared to same quarter last year (-58.9%) but similar to previous quarter.

YearQ1Q2Q3Q4
2019299
363
21.4% QoQ
475
30.9% QoQ
200
-57.9% QoQ
2020 277
-7.4% YoY 38.5% QoQ
350
-3.6% YoY 26.4% QoQ
247
-48.0% YoY -29.4% QoQ
223
11.5% YoY -9.7% QoQ
2021 286
3.2% YoY 28.3% QoQ
246
-29.7% YoY -14.0% QoQ
232
-6.1% YoY -5.7% QoQ
200
-10.3% YoY -13.8% QoQ
2022 198
-30.8% YoY -1.0% QoQ
258
4.9% YoY 30.3% QoQ
217
-6.5% YoY -15.9% QoQ
224
12.0% YoY 3.2% QoQ
2023 302
52.5% YoY 34.8% QoQ
280
8.5% YoY -7.3% QoQ
361
66.4% YoY 28.9% QoQ
134
-40.2% YoY -62.9% QoQ
2024 53
-82.5% YoY -60.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Kineta search interestLast update: February 09 2024 04:45:13.
Correlation coefficient between keyword and revenue is 0.28
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 04:45:15.

The average 5 years interest of Kineta was 20.79 per week.
The last year interest of Kineta compared to the last 5 years has changed by -7.98%.
The interest for Kineta is seasonal.
The last year interest is quite lower compared to 5 years ago. It has decreased by -35.06%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Kineta Kineta biotechnology to provide analysis

Correlation between past revenue and Kineta Kineta biotechnology search interest

There is not enough data for Kineta Kineta biotechnology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Kineta Kineta biotechnology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Kineta immunotherapies to provide analysis

Correlation between past revenue and Kineta immunotherapies search interest

There is not enough data for Kineta immunotherapies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Kineta immunotherapies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Kineta clinical-stage to provide analysis

Correlation between past revenue and Kineta clinical-stage search interest

There is not enough data for Kineta clinical-stage to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Kineta clinical-stage to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for KVA12123 to provide analysis

Correlation between past revenue and KVA12123 search interest

There is not enough data for KVA12123 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for KVA12123 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for KVA12123 clinical trials to provide analysis

Correlation between past revenue and KVA12123 clinical trials search interest

There is not enough data for KVA12123 clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for KVA12123 clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for anti-VISTA antagonist mAb immunotherapy to provide analysis

Correlation between past revenue and anti-VISTA antagonist mAb immunotherapy search interest

There is not enough data for anti-VISTA antagonist mAb immunotherapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for anti-VISTA antagonist mAb immunotherapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for anti-CD27 agonist mAb immunotherapy to provide analysis

Correlation between past revenue and anti-CD27 agonist mAb immunotherapy search interest

There is not enough data for anti-CD27 agonist mAb immunotherapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for anti-CD27 agonist mAb immunotherapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for KA
Earnings date: 2024-03-29 After close
Company name: Kineta Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2024-10-02T16:07:07-04:00

SEC
8-K Form - Current report, items 8.01 and 9.01 - KINETA, INC./DE (0001445283) (Filer)

2024-09-19T21:53:51-04:00

SEC
8-K Form - Current report, items 8.01 and 9.01 - KINETA, INC./DE (0001445283) (Filer)

2024-09-13T17:20:08-04:00

SEC
8-K Form - Current report, items 1.01, 2.03, and 3.01 - KINETA, INC./DE (0001445283) (Filer)

2024-09-05T16:21:48-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - KINETA, INC./DE (0001445283) (Issuer)

2024-09-05T16:21:14-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - KINETA, INC./DE (0001445283) (Issuer)

2024-09-05T16:20:49-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - KINETA, INC./DE (0001445283) (Issuer)

2024-09-05T16:20:19-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - KINETA, INC./DE (0001445283) (Issuer)

2024-09-05T16:19:48-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - KINETA, INC./DE (0001445283) (Issuer)

2024-09-05T16:19:07-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - KINETA, INC./DE (0001445283) (Issuer)

2024-09-05T16:18:34-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - KINETA, INC./DE (0001445283) (Issuer)

2024-08-19T09:01:45-04:00

SEC
8-K Form - Current report, items 8.01 and 9.01 - KINETA, INC./DE (0001445283) (Filer)

2024-08-19T13:00:00Z

GlobeNewswire
Kineta Reopens Enrollment for the VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer

2024-08-19T09:00:00-04:00

PR Newswire
TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer

2024-08-08T16:00:35-04:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - KINETA, INC./DE (0001445283) (Filer)

2024-07-08T06:30:46-04:00

SEC
8-K Form - Current report, items 1.01 and 9.01 - KINETA, INC./DE (0001445283) (Filer)